Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT02028650
Eligibility Criteria:
Inclusion Criteria:
* Eligible patients were between 9 and 67 years of age with de novo diagnosed or treated-related Acute leukemia relapsed after HLA-matched hematological stem cell transplantation from Feb 2005 to Feb 2013
* Relapse was morphologically and molecularly diagnosed,with the help of cytogenetic and engraftment.
* Eastern Cooperative Oncology Group (ECOG) performance status was 0 to 2
Exclusion Criteria:
* Patients without receiving CR will not receive further post-remission trial therapy
* The patients of AML-M3 were excluded from this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
9 Years
Maximum Age:
67 Years
Study:
NCT02028650
Study Brief:
Protocol Section:
NCT02028650